Hyperbaric oxygen therapy for aging is one of the most actively investigated areas of geroscience. The Tel Aviv 2020 trial is the headline study, and follow-on work from the Sagol Center has reproduced and extended the findings in cognitive function, cardiac ejection fraction, gene expression, and other markers. Still — the literature is building.
We are not claiming HBOT cures aging. We are not claiming any specific outcome is guaranteed for any specific buyer. We are not selling a clinical service or making medical claims about your individual health.
We are claiming the research is good enough — and the access is now home-practical enough — that a sophisticated buyer over fifty should know what the evidence actually shows. You decide what to do with the information.
Our role is narrower: connect you with a chamber whose engineering meets the standards used in the studies, install it correctly, and stay with you for the life of the equipment.